Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.10
0.03 (2.80%)
At close: Aug 15, 2025, 3:59 PM
1.12
1.36%
After-hours: Aug 15, 2025, 07:51 PM EDT
Allogene Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 52.33M | 42.45M | 75.22M | 51.24M | 170.67M | 51.04M | 83.16M | 69.25M | 154.76M | 514.01M | 576.47M | 74.36M | 96.04M | 84.51M | 809.48M | 190.02M | 223.5M | 236.87M |
Short-Term Investments | 220.79M | 237.59M | 217.26M | 240.32M | 273.96M | 333.82M | 365.54M | 396.26M | 337.2M | 361.29M | 455.42M | 477.87M | 394.45M | 364.54M | 283.99M | 293.46M | 364.2M | 462.72M |
Long-Term Investments | 29.51M | 55.51M | 80.67M | 111.82M | 11.43M | 25.41M | 3.65M | 47.83M | 62.5M | 53.91M | 59.15M | 99.15M | 211.33M | 298.3M | 370.18M | 396.13M | 344.34M | 283.92M |
Other Long-Term Assets | 37.6M | 33.83M | 33.39M | 37.58M | 27.87M | 5.16M | 16.9M | 9.58M | 19.67M | -12.87M | 32.67M | 19.67M | 19.23M | 19.33M | -322.05M | 15.61M | 15.28M | 15.72M |
Receivables | n/a | 2.3M | 1.9M | 2.8M | 2M | 1.7M | 1.7M | 1.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -1.7M | -1.6M | -1.1M | -12.44M | -62.45M | n/a | -11.9M | -11.3M | -20.02M | -9.4M | -4.3M | -4.5M |
Other Current Assets | 9.54M | 9.23M | n/a | 10.05M | 10.5M | n/a | 10.42M | 7.95M | 10.14M | 10.24M | 11.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 282.65M | 291.58M | 303.39M | 304.42M | 457.12M | 395.36M | 459.12M | 473.45M | 502.1M | 514.01M | 528.82M | 569.06M | 513.03M | 469.74M | 809.48M | 502.86M | 602.17M | 716.06M |
Property-Plant & Equipment | 120.82M | 127.07M | 131.26M | 135.3M | 150.47M | 160.41M | 163.18M | 181.47M | 186.7M | 191.81M | 196.43M | 199.69M | 204.05M | 177.26M | 181.02M | 164.65M | 164.93M | 163.34M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 187.94M | 216.41M | 245.32M | 284.7M | 189.76M | 190.99M | 183.72M | 238.87M | 268.87M | 232.86M | 288.25M | 318.51M | 434.62M | 494.89M | 229.15M | 576.39M | 524.55M | 462.98M |
Total Assets | 470.59M | 507.98M | 548.71M | 589.12M | 646.88M | 586.35M | 642.84M | 712.33M | 770.97M | 746.87M | 817.08M | 887.57M | 947.64M | 964.63M | 1.04B | 1.08B | 1.13B | 1.18B |
Account Payables | 4.85M | 5.06M | 5.39M | 5.51M | 12.94M | 5.78M | 5.9M | 6.21M | 10.23M | 14.69M | 13.89M | 11.04M | 9.71M | 8.71M | 10.26M | 11.5M | 11.01M | 14.88M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 86K | 86K | 236K | 229K | 273K | 885K | 889K | 836K | 406K | 423K | 365K | 305K | 239K |
Short-Term Debt | n/a | 7.63M | 7.51M | 7.39M | 7.22M | 6.93M | 6.78M | 6.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 31.68M | n/a | 4.64M | -7.39M | -14.44M | -13.86M | 4.88M | -6.58M | n/a | n/a | 17.93M | -5.83M | -5.34M | n/a | 18.17M | n/a | n/a | n/a |
Total Current Liabilities | 31.68M | 30.02M | 35.52M | 32.57M | 37.3M | 30.89M | 37.08M | 37.64M | 54.72M | 59.59M | 54.52M | 48.87M | 44.91M | 36.88M | 48.17M | 53.49M | 46M | 54.85M |
Long-Term Debt | 79.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 15.12M | 11.28M | 7.76M | 7.67M | 7.55M | 5.17M | 5.18M | 1.49M | 1.52M | 1.51M | 1.57M | 2.03M | 2.55M | 3.49M | 4.13M | 5.17M | 5.71M | 2.79M |
Total Long-Term Liabilities | 94.36M | 92.57M | 91.01M | 92.8M | 94.54M | 94.09M | 93.53M | 91.59M | 93.34M | 95.02M | 96.69M | 98.74M | 100.79M | 72.53M | 74.05M | 55.81M | 56.91M | 54.42M |
Total Liabilities | 126.03M | 122.59M | 126.53M | 125.37M | 131.84M | 124.98M | 130.6M | 129.22M | 148.06M | 154.61M | 151.21M | 147.61M | 145.69M | 109.4M | 122.23M | 109.3M | 102.91M | 109.27M |
Total Debt | 79.24M | 81.29M | 90.76M | 85.14M | 94.21M | 95.85M | 95.12M | 96.68M | 91.82M | 99.7M | 95.12M | 96.71M | 98.23M | 69.03M | 69.93M | 50.64M | 51.21M | 51.63M |
Common Stock | 220K | 219K | 212K | 210K | 209K | 170K | 169K | 168K | 167K | 146K | 144K | 144K | 144K | 143K | 142K | 142K | 142K | 141K |
Retained Earnings | -1.93B | -1.88B | -1.82B | -1.76B | -1.69B | -1.63B | -1.56B | -1.47B | -1.41B | -1.33B | -1.24B | -1.14B | -1.06B | -983.2M | -903.35M | -828.48M | -750.29M | -679.36M |
Comprehensive Income | -45K | 43K | -89K | 157K | -780K | -927K | -955K | -2.41M | -3.85M | -5.93M | -9.93M | -12.96M | -11.47M | -9.25M | -2.57M | -398K | -334K | -101K |
Shareholders Equity | 344.56M | 385.39M | 422.18M | 463.75M | 515.04M | 461.37M | 512.23M | 583.1M | 622.91M | 592.26M | 665.87M | 739.96M | 801.95M | 855.23M | 916.41M | 969.94M | 1.02B | 1.07B |
Total Investments | 250.3M | 293.09M | 297.93M | 352.15M | 285.39M | 359.23M | 369.19M | 444.09M | 389.79M | 404.08M | 514.57M | 580.03M | 605.78M | 662.83M | 654.17M | 689.6M | 708.55M | 746.64M |